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Mathematical and statistical methods enable multidisciplinary approaches that
catalyse discovery. Together with experimental methods, they identify key
hypotheses, define measurable observables and reconcile disparate results.
We collect a representative sample of studies in T-cell biology that illustrate
the benefits of modelling–experimental collaborations and that have proven
valuable or even groundbreaking. We conclude that it is possible to find excel-
lent examples of synergy between mathematical modelling and experiment in
immunology, which have brought significant insight that would not be
available without these collaborations, but that much remains to be discovered.1. Introduction
Mathematics has a long tradition in biology and medicine, going back at least to
Gregor Mendel’s work in genetics and Theodor Boveri’s work on the nature of
the chromosomes [1]. However, as the various subfields have become more
specialized, and understanding of biological systems more detailed, modelling
has often been dismissed or ‘regarded with suspicion, partly because much
modelling seems an empty intellectual exercise that fails to deliver biological
insight’ [2]. In immunology, the situation is not much different [3]. Some com-
monly cited reasons for the separation between experimental immunology and
mathematical modelling are (i) the pace of discovery of new agents and new
phenomena in the immune system, accompanied by new jargon, (ii) the rapid
advance of technology, producing ever more data, and (iii) the contrast in aca-
demic environments, culture and terminology. In our view, these issues (at least
the first two) are in fact reasons why mathematical modelling will become
increasingly important in immunology (and other fields of biology) [4]. It is pre-
cisely because intuition is insufficient beyond a certain level of complexity that
analysis of the immune system must become more quantitative [5–7].
As experimental data expose the complexity of the immune system, its non-
linearities [3], feedbacks [8], combinatorial complexity [9] and redundancies
[10], it becomes ever more difficult to understand from a purely descriptive
and qualitative viewpoint. On the other hand, big data and the so-called infor-
mation explosion [11] have attracted attention as they promise automatic
(computerized) solutions to biological and medical problems. The strategy
behind this approach, referred to as data-driven modelling [12] or reverse model-
ling [13], is the use of statistical data analysis with the aim of creating novel
knowledge. However, statistical analysis is only one of the many tools that
mathematics can provide to immunology and, in general, cannot offer mechan-
istic explanations. Nor are computational models that include every known
agent and interaction sufficiently well developed, yet, to replace animal testing.
Current models, using differential equations, the theory of stochastic processes
and agent-based simulations [14], are ‘often derived from phenomenology and
guess work’ [13]. Their first benefit is that building the model forces the mod-
eller to lay out all assumptions clearly. Thus, a mathematical model is an
accurate description of current, incomplete, thinking, not a complete or accurate
description of Nature itself.
Immunology is an excellent field for the application of mathematics,
because it has a long tradition of important theories (clonal selection,
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[15]. Still, there are impediments to a marriage of mathemat-
ics and immunology [3]. One is that the technical languages
of the disciplines are very different. It would be useful for
experimental immunologists to have some basic understand-
ing of mathematical modelling, its usefulness and limitations;
it is also crucial that modellers learn the required immu-
nology and the experimental systems they are modelling.
That is, we have to overcome the third problem identified
above. On the other hand, there are examples of successful
collaborations between experimental and mathematical
immunologists. Often, but not exclusively, these partnerships
are more fruitful when collaborations are initiated at an early
stage of a given study.
Our aim here is not to review the impact of theoretical
ideas in immunology, nor to provide a mathematical tutorial.
We instead emphasize the role that mathematical (or compu-
tational) modelling has already played in immunology. We
present examples from the literature of the contribution of
mathematics to T-cell immunology under four headings:
(i) generation of hypotheses, (ii) quantification of immuno-
logical processes, (iii) definition of observables to measure
given an experimental objective, and (iv) reconciling
disparate (or even conflicting) experimental results.
With our examples, we seek to illustrate the power that,
together, mathematical and experimental immunology have
to elucidate the behaviour of one of the most intricate systems
that evolution has produced. To Dobzhansky’s [16] statement
that ‘nothing in biology makes sense except in the light of
evolution’, we may add that nothing can be expressed
quantitatively in science except in the light of mathematics.2. Generating hypotheses
2.1. T-cell movement: directed or random?
T cells interact in lymph nodes (LNs) with antigen presenting
cells (APCs) that display peptide–MHC complexes (small
fragments of proteins bound to MHCmolecules) on their sur-
face. From the point of view of a naive T cell that spends a
day or less in an LN, searching for an APC with a few cognate
peptide–MHC complexes is a ‘needle in a haystack’ problem
[17,18]. Based on twentieth-century understanding of cell
types and the means by which cells communicate and
home to different organs [17], derived from in vitro studies
and snapshot images, the natural hypothesis was that, in
the LNs, T cells are guided to their target APCs by
chemokine-derived signals.
A new hypothesis emerged from three papers, published
together in 2002, where Miller et al. [19], Stoll et al. [20] and
Bousso et al. [21] reported in vivo imaging studies (using
two-photon microscopy) in which individual T and B cells
were resolved and tracked: the first direct in situ observations
of their movement and interaction with dendritic cells (DCs).
Movies were produced by stacking two-dimensional slices
into three-dimensional images, then into series of three-
dimensional images taken at regular time intervals, a
minute or less apart. In the movies, ‘rather than directed
motion in response to sustained chemokine gradients along
structural pathways’, T-cell motion is seen to be rapid, and
described as ‘meandering’, ‘chaotic’, ‘random’ and ‘frantic’
[22,23]. The data available are the estimated positions of the
centres of a set of labelled cells in three-dimensional spaceat a series of times: xi(t), yi(t), zi(t), where i labels the cell
track and t labels time: t ¼ 0, Dt, 2Dt, . . . , with Dt, the time
interval between images. It is well known from modelling
of, for example, Brownian motion that, if the movement is
indeed random, the means of xi(t)2xi(0), yi(t)2yi(0) and
zi(t)2zi(0) are zero, but the mean of the displacement from
the initial position,
riðtÞ ¼ ððxiðtÞ  xið0ÞÞ2 þ ðyiðtÞ  yið0ÞÞ2 þ ðziðtÞ  zið0ÞÞ2Þ1=2,
is not vanishing. When Miller et al. plotted the mean displace-
ment against the square root of time, points fell ‘on straight
lines, consistent with the hypothesis of random movement; the
slope is the motility coefficient M’ [19,24]. Thus, in an opinion
article in 2003, Cahalan et al. [25] argued for the new hypothesis
‘that lymphocytes migrate randomly within lymphoid organs,
and that lymphocyte contactwithAPCsmay be a stochastic pro-
cess rather than one guided by chemokine gradient’. The ‘key
point is that vigorous motility in a random walk characterises
the behaviour of naive T cells in vivo’.
However, the situation is not so simple, because there can
be subtle biases in cell tracks pieced together from two-
photon imaging data [26], which are limited in both space
and time. For example, directed movement in an environ-
ment full of physical obstacles (other cells and the
endothelial reticular network) could still look approximately
random. The best way to analyse these biases is to use math-
ematical models, which not only provide qualitative clues
about the underlying mechanisms but, more importantly, in
those cases where the true answer lies somewhere in the
middle of two or more competing hypotheses, can describe
quantitatively the way in which those different mechanisms
are combined in the experiment, and identify additional
experiments (for instance, inhibiting one mechanism) to test
the validity of the model and gain a deeper biological insight.
Indeed, departures from a straight line in plots of mean
displacement versus the square root of time are seen at suffi-
ciently short and long times, indicating possible persistence
in T-cell motion and an effect of confinement and finite ima-
ging volumes. To analyse cell tracks in more detail and to
compare them with theoretical predictions from random
versus directed motion, the dependence on Dt of the distri-
bution of the apparent speed, viðtÞ ¼ ½riðtþ DtÞ  riðtÞ=Dt,
and the distribution of turning angles can be used [27–32].
These analyses have been applied to studies of the role of
the LN reticular network [33–36], of the effect of localized
chemotactic migration [37], and to extrapolate from the
high density of labelled cells necessary for two-photon ima-
ging to lower, more physiological, cell densities [38]. For
example, careful mixed effects analysis is required to identify
a small directed component of the motion of skin-resident T
cells [39–41] towards a site of infection.
Not all T cells in LNs crawl vigorously; also noted in the
early imaging studies were apparently stationary cells, clus-
ters of cells and swarms of enlarged T cells that repeatedly
come into contact with DCs bearing cognate antigen [24].
Bousso & Robey [42] estimated that seven new T cells per
minute came into close contact with each individual DC,
and extrapolated to conclude that each DC can contact
about 500 different T cells in an hour. The description of
Mempel et al. [43], in which T-cell priming by DCs in LNs
occurs in three phases, has been very influential [22]. In the
first of these phases, T cells contact antigen-bearing DCs
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increase in the second phase and, in the third phase, T cells
resume their motility, swarm in the local vicinity, begin the
process of cell division and initiate interaction with B cells.
More sophisticated models of cell motion in the LN (such
as those based on cellular automata, where cells move only
according to stochastic local rules) can include these different
phases, and try to use experimental data to calibrate the rates
of T-cell interactions with other cells [36]. In yet more
advanced computational models [44,45], called cellular Potts
models [46,47], T cells are simulated as extended entities,
that is, cells have shape (which can change over time) and
sites that contact other cells, and occupy a physical space
determined by their flexible cellular membrane. Each cell is
assumed to minimize its surface energy. This gives rise to
changes in the cell’s configuration and to its movement
over the course of time [48]. Extrapolating from experimental
data, these models predict that an individual T cell can scan
up to a hundred different DCs per hour [44].
These more complicated models allow detailed incorpor-
ation of random and directed components of the movement,
with different hypotheses and taking into account the com-
plexity of the LN environment. Moreover, they not only
simulate the dynamics of cells in the LN, but one can also
simulate the experimental measurements, including the
effects of limited time and space resolution to clarify our
interpretation of the experimental data. For example, it is
possible to track single cells in a two-dimensional plane (or
stack of two-dimensional planes) for a limited time, and
plot their displacement. Thus, in this field of immunology,
we find an example of a hierarchy of models, from simple
functions to complex computer simulations, that provide
more detailed analyses and insights into valuable experi-
mental data and alternative hypotheses to explain T-cell
migration in LNs. It is likely that both directed and
random components are involved in T-cell movement, and
this could depend on the type or state of the T cell. The
final verdict is still unknown. Clearly, further rounds of
observation–modelling–prediction–observation are needed
to advance our understanding of how T cells move and inter-
act with other cells, and how these interactions allow the
specific pMHC–TCR interactions that initiate adaptive
immune responses [49–51].2.2. T-cell activation: how are signals integrated?
Adaptive immune responses to infection mediated by CD8þ T
cells are characterized by the following time course: a subset of
CD8þ T cells, those that are pathogen-specific, undergoes
rapid proliferation, expanding the cell numbers of the given
subsets, followed by population contraction owing to cell
death and a return to homeostasis of the CD8þ T-cell popu-
lation. T-cell activation and proliferation require a number of
receptor-mediated signals. How are CD8þ T-cell stimulatory
signals integrated and how do they relate to the strength of
the T-cell response? A recent joint experimental andmodelling
effort by Marchingo et al. [52] has provided some answers,
whereas previous efforts had been limited to qualitative
approaches that do not predict the quantitative effect of
altering a combination of stimulatory signals.
The current paradigm is that T cells respond to three sig-
nals: signal 1 (or s1) is received by the T-cell receptor (TCR)
upon ligand binding to peptide–MHC complexes, signal 2(or s2) is co-stimulatory and provided by APCs that express
ligands, CD80 and CD86, that can bind co-stimulatory recep-
tors (CD28 and CTLA-4) on the surface of T cells, and signal 3
(or s3) is provided by cytokines (such as interleukin (IL)-2,
IL-4 or IL-7). As mentioned above, there is an important
difference between a qualitative hypothesis (the three signals
are needed) and a quantitative/mathematical one (which math-
ematical function describes the relative weight of these three
signals).
Previous work on B cells by the same authors led them to
conclude that B-cell immune responses involve an automated
programme of proliferation events, characterized by the
number of total divisions and a return to cell quiescence
[53–55]. These experimental studies also showed that the
number of division events was influenced by the strength
of B-cell stimulation. They hypothesized a similar pro-
gramme for T cells, namely the final number of divisions
during a CD8þ T-cell-mediated immune response is a
(linear) function of the sum of signals, s1, s2 and s3. The rel-
evance of this hypothesis, if true, is the potential to predict
therapeutic strategies of immunomodulation. Furthermore,
the hypothesis naturally leads to the development of a quan-
titative (mathematical and computational) framework to
relate the signals received by a given T cell to its behaviour
during an immune response as a function of time.
Marchingo et al. [52] used the concept of division destiny
(DD) of a T cell: the number of rounds of division before the
cell returns to quiescence or dies. This concept was introduced
in a paper describing the ‘cytonmodel’ of lymphocyte prolifer-
ation [53]. In this model, each cell has autonomous division
and death processes in competition, corresponding (math-
ematically) to countdown clocks for these two fates (division
or death). The start time for each clock is an independent
random variable. The outcome for the cell is determined by
whichever clock reaches zero earlier. DD is the maximum
number of divisions allowed in the model [52,53].
A series of experiments allowed them to analyse how DD
varies with different combinations of signals and to calibrate
the cyton model to compute DDs [53,56,57]. Additionally, an
in vivo experiment enabled them to test their hypothesis with
a set of untrained data. Putting all these together, the authors
then concluded that, both in vitro and in vivo, CD8þ T-cell-
mediated immune responses imply two stages of regulation
of T-cell DD. During the first stage,s1, s2 and s3 additively pro-
gramme a heritable number of division rounds before the first
cell division. The second stage, which involves external stimuli,
such as cytokines, can further increase the DD of a given cell.
The experimental approach of Marchingo et al. [52] makes
use of transgenic mice with CD8þ T cells that only express
one TCR, the OT-I receptor, crossed with fluorescent ubiqui-
tination-based cell-cycle indicator red–green (FucciRG)
reporter mice. The cell cycle is tightly regulated by specific
proteins that are produced and degraded in a highly con-
trolled fashion. The FucciRG reporter was developed by
fusing red and green fluorescent proteins to two cell-cycle
regulators, which are expressed at different times [58,59].
(More specifically, the reporter is based on the fact that the
cell cycle is not only regulated at the transcriptional and
post-translational levels, but also controlled by ubiquitin-
mediated proteolysis. The authors harnessed the regulation
of cell-cycle-dependent ubiquitination in order to develop
two genetically encoded indicators for cell-cycle progression
[58], hence the name, fluorescent ubiquitination-based cell-
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ing the CD8þ T cells of the mice used) fluoresce red if they
are in the G0/G1 phase, or green if they are in the S/G2/M
phase of the cell cycle, and the cells can be classified as quies-
cent, recently divided or actively dividing. We should
emphasize that the development of this reporter construct
was a great technical achievement owing to the heroic efforts
of Sakaue-Sawano et al. [58], opening doors for beautiful and
important experiments [60]. Indeed, this is a very good
example where new technology allows new insights into
the biology, driving hypothesis formulation and model
development.
Marchingo et al. [52] used the cyton model to fit data from
FucciRG mice, allowing them to conclude that DD is around
10 generations (or divisions), yet different T-cell families
differ in numbers, with differences up to three orders of
magnitude.1
A second experimental model is an in vitro cell-trace-violet
(CTV) division-tracking assay, to allow further exploration of
the division progression. With this in vitro experimental
system, the authors stimulated CTV-labelled OT-I-specific
CD8þ T cells with a combination of signals s2 and s3 (see
fig. 2 in [52]), and carried out a titration study for cytokine
IL-2 (human). Again, fitting the data to the cyton model
enables the authors to estimate the average DD of the popu-
lation, to obtain a beautiful time course and dose–response
curves based on the linearity hypothesis (Marchingo et al.
[52] fig. 2c,d). Their in vitro CTV data support the hypothesis
that summation of DD from multiple co-stimuli geometrically
amplifies the T-cell response [52]. With these two sets of exper-
iments, the authors make two key predictions. The first one is
the additive nature of the T-cell stimuli in vivo, and the second
one is that the second stage, which allows the extension of
the DD of a given cell, will be more relevant away from the
site of priming.
To test these predictions, the authors carried out a final
set of experiments that involved co-transfer of T cells to
mice infected with two different recombinant influenza
viruses. One set of mice was infected with a virus expressing
the low-affinity ovalbumin peptide Q4 (low affinity for the
OT-I TCR expressed by the transferred cells), and a second
set of mice was infected with an influenza virus expressing
the high-affinity peptide N4 (high affinity for the OT-I
TCR). The co-transfers involved two kinds of cells: wild-
type (WT) OT-I CD8þ T cells and OT-I CD8þ T cells lacking
the high-affinity IL-2 receptor (IL-2Ra or CD25) (mutant), so
that they cannot receive IL-2-derived cytokine signals. Thus,
in total, the experiments generated four sets of data:
(i) high TCR signal (N4 peptide) and high IL-2R signal
(WT cells), (ii) high TCR signal (N4 peptide) and low
IL-2R signal (mutant cells), (iii) low TCR signal (Q4 peptide)
and high IL-2R signal (WT cells), and (iv) low TCR signal (Q4
peptide) and low IL-2R signal (mutant cells). The authors
fitted the cyton model to data from (ii), (iii) and (iv) to predict
the effect of each signal (in this case, s1 and s3) on the distri-
bution of DD for the experimental conditions from (i). Based
on that distribution, the authors were able to compute/pre-
dict the dynamics of the T-cell population over time, which
showed good agreement with the experimental data.
This is one of the few (thus far) examples in which exper-
iments and modelling have gone hand-in-hand and
completed the full circle of: (i) experimentation, (ii) hypoth-
esis generation, (iii) further experimentation, (iv) modeldevelopment, (v) model prediction, and (vi) model validation
with a final and independent set of experiments. The rel-
evance of this study is multiple: first, it has managed to
resolve long-standing discrepancies between in vitro and in
vivo systems; second, it has provided a quantitative and pre-
dictive framework that underpins the time course of CD8þ
T-cell responses for a combination of stimuli. Finally, this
quantitative framework will allow further in silico testing
for combinations of stimuli that might not be experimentally
feasible now, yet relevant to the development of future
immunotherapeutic strategies.3. Defining what to measure
3.1. T-cell receptor excision circles to measure thymic
output
To understand healthy homeostasis and disease dysregula-
tion of the peripheral T-cell compartment, it is important to
quantify thymic output [61]. However, there is no simple
way to perform this quantification experimentally in
humans (or mice). Ideally, recent thymic emigrants (RTEs)
would express some surface protein with a short half-life
that could be measured. This knowledge, together with the
levels of cells expressing that protein in the periphery,
would allow the calculation of thymic export, assuming
RTEs did not proliferate, at least while expressing the identi-
fier protein. This situation is the case in chicken, where the
chT1 antigen on thymic T-cell precursors seems to fulfil this
role [62]. In mammals, there is no such convenient marker,
but it was proposed that one could use T-cell receptor
excision circles (TRECs) to quantify thymic output [63,64].
TRECs are episomal DNA circles that are a by-product of
TCR rearrangement. During T-cell development in the
thymus, the a chain of the TCR is rearranged by recombina-
tion of its subcomponents (the variable and joining regions)
on chromosome 14, which involves excision of the d locus
that resides between the V and J segment genes of the a
chain on that chromosome. The excised DNA circularizes
and contains specific sequences (so-called signal-joint and
coding-joint) that are common on 70% of ab T cells [63,64].
These TRECs have properties that make them good candi-
dates for markers of RTEs with which one could quantify
thymic output. In particular, they are stable [64,65], they do
not divide [63], they are of exclusive thymic origin
[63,64,66], they are identical in 70% of ab T cells [67], and
they mark RTEs in chicken [64].
Several groups used TRECs to quantify thymic output,
especially in the context of HIV infection, because this infec-
tion leads to declining T-cell numbers and it was not clear
what the contribution of a lower thymic output was
[63,68,69]. In these studies, TRECs were reported as fre-
quency of TRECþ cells among all CD4þ T cells (or,
sometimes, naive CD4þ T cells or peripheral blood mono-
nuclear cells (PBMCs)). It was found that TREC frequency
decreases with age [63,68], that it is lower in HIV-infected
individuals [63,68], although for many this frequency was
in the normal range [68], and that it increases significantly
in antiretroviral-treated HIVþ individuals, who have a
lower than normal TREC frequency [63,68]. Another early
study indicated that TREC frequency was a predictor,
beyond viral load and CD4þ T-cell count, of the rate of
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what different conclusions, with some stating that RTEs
and thymic output, as measured by TREC frequency, had
an important role in HIV disease [63,69], and others conclud-
ing that ‘it is difficult to invoke thymic regenerative failure as
a generalised mechanism for the depletion of CD4þ lympho-
cytes’ and ‘we therefore caution against the use of such
phenotypic markers as a direct indicator of thymic output’
[68]. This initial research was followed by a flurry of studies
using TRECs to quantify thymic output [61,70–72].
One problem with the interpretation of TREC frequency
is that it can vary owing to changes in both cells with
TRECs (the numerator) and cells without TRECs (in the
denominator). Thus, other dynamical processes besides
thymic input into the periphery, such as T-cell proliferation
or death, could influence the observed changes in TREC
frequency. For example, T-cell proliferation of non-TREC-
containing cells would lead to a decrease in TREC fre-
quency, and it is well known that T-cell proliferation is
increased in the context of HIV infection (see below). This
problem was recognized and explicitly mentioned by the
initial studies [63,64,68], and the assumptions about the
importance of this issue affected the conclusions drawn by
those authors.
This is a case where modelling can help clarify the
interpretation of the data by identifying what to measure,
and it can be argued that one must use a model to properly
analyse the data. Exactly this was proposed in a seminal
study, where a simple mathematical model was used to inter-
pret TREC frequency data [73]. The model equations for
TREC-containing cells (C ) and total T cells (T ) are [73]
dC
dt
¼ as dC ð3:1Þ
and
dT
dt
¼ sþ ðp dÞT, ð3:2Þ
where s is the output of the thymus, a is the fraction of cells
exiting the thymus that contain a TREC and p and d are the
rates of proliferation and death of T cells, respectively. The
ordinary differential equations (3.1) and (3.2) are linear and,
thus, most simple, yet allow one to explain the experimental
data. In particular, with these assumptions for the dynamics
of T cells, TREC frequency (F ¼ C/T ) is given by the division
rule of differentiation and one obtains
dF
dt
¼ as
T
 p s
T
 
F: ð3:3Þ
Equation (3.3) shows that the dynamics of TREC frequency
depends explicitly on thymic output and also on the prolifer-
ation rate p, and cannot simply be interpreted directly as
thymic output [74]. Hazenberg et al. [73] went on to analyse
the predicted dynamics in the context of ageing, HIV infection
and HIV treatment, and concluded that ‘loss of TREC in HIV-1
infection may primarily be caused by continuous hyper-acti-
vation of the immune system as reflected by increased cell
division’ and ‘measurements of TREC content (. . .) fail to
provide experimental evidence for thymic impairment’.
The contribution from the mathematical model was to clar-
ify the assumptions madewhen thinking of TREC frequency as
a direct measurement of thymic output, demonstrating that
such interpretation of the datawas abusive.However, themath-
ematical model also suggests that proper assessment of thymicoutput may be possible using TREC concentration (i.e. TRECþ
cells per microlitre of blood), which is described by equation
(3.1). This is clear from inspection of the equation, but was not
realized until models of the systemwere developed. Measuring
TREC per microlitre became an important variable in studies
trying to understand the effects of thymic output [75–79], and
also a relevant issue for model development [74,80–82]. In par-
ticular, equation (3.1) states that total abrogation of thymic
output should result in an exponential decay in TREC concen-
tration, and analyses of such data would allow estimation of
the parameter d (the slope of that decay). Moreover, if we
assume that TREC concentration is at an approximate steady
state (C0) before abrogation of thymic output, then one can esti-
mate thymic output as as¼ dC0. Thus, the model suggests an
experiment of thymectomy (removal of the thymus). This exper-
iment was performed on a macaque model of HIV infection,
allowing direct quantification of the number of CD4þ and
CD8þ T cells exported from the thymus (of rhesus macaques)
per day [83].
The study of TRECs shows how development of novel
experimental and technical capabilities can be leveraged
even with simple mathematical models. It is clear that the
model presented in (3.1)–(3.3) is a simplified description of
complicated biological phenomena, and yet this approach
was highly valuable to properly interpret new datasets.4. Quantifying immunological processes
4.1. Estimating T-cell receptor diversity
The number of different TCRs that could be produced by the
processes of DNA rearrangement that occur in the thymus is
enormous, far greater than the total number of cells in a
human body [84]. A first question is: how many different
TCRs are found at any one time in one mouse or human?
Let us denote this quantity by N(t). With the slight simplifi-
cation that all the TCRs on the surface of any one T cell are
identical, the T-cell repertoire can be divided into clonotypes,
each clonotype characterized by a unique TCR. If ni(t), i ¼ 1,
. . . ,N(t) is the number of T cells expressing TCR of type i at
time t, then we can pose a second question: what is the
distribution of values of ni(t)?
The TCR is formed in the thymus by pairing a larger b chain
and a smallera chain. TheDNAsubset that encodes theb chain,
TRB, is formed by rearranging V, D and J gene segments, plus
additional nucleotide rearrangements at V–D and D–J junc-
tions. TCRA, which encodes the a chain, rearranges with V
and J only. Assuming that the TCR nucleotide sequence pro-
vides a unique molecular tag for each clonotype, the total
number of distinct TCR sequences in a body is equal to N(t). A
new field of immunosequencing has emergedwith technologies
designed to sequence TCRs [85]. Millions of TCR sequences can
be amplified in a single multiplex polymerase chain reaction
(PCR), prepared and then read in parallel from a single
sample. The distribution of VJ gene segment usage can be
measured with flow cytometry [86,87], and used to track
changes with age and between individuals [88,89].
In 1999, Arstila et al. [90] published a first estimate of the
number of distinct TCRb chains in a sample of 108 T cells
from a healthy donor. By sequencing only DNA from cells
that use VB18 (estimated to be 0.8% of T cells), VJ1.4 (estimated
to be 3% of T cells) and with a CDR3 length of 12 amino acids
(estimated to be 9.3% of T cells), they were able to identify 17
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Figure 1. Simulated sampling from repertoires. In each of the three simulated examples shown, a sample of 2000 cells is selected from a repertoire that contains
10 million cells divided into 1 million different clonotypes. (a) The three examples have different distributions of clonal sizes, ni. In the first, every clonotype consists of 10
cells (a(i)). In the second, the number of cells per clone is drawn from a geometric distribution with mean 10 cells (a(ii)). The third example is similar to the second, but
200 ‘expanded’ clonotypes have sizes drawn from a geometric distribution with mean 1000 cells (a(iii)). (b) Histograms of the samples (of 2000 cells) from each
repertoire. The number of cells, si, of a clonotype, i, that is present in the sample is most often equal to 1. Only in (b(iii)), where there are expanded clonotypes
in the repertoire, are there more than two cells of some clonotypes in the sample. (Online version in colour.)
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blood sample contained 17/(0.008 0.03 0.093) ¼ 0.8  106
distinct TCRb chains. Fifteen sequences from the same
sample, restricted to VB16, VJ2.2 and CDR3 length of 13
amino acids, gave a similar estimate of TCRb diversity, close
to 106. Subsequent studies have tended to restrict themselves
to analysing the b chain, believed to contain the majority of
TCR diversity. The estimate of 106 TCRb chains in human
blood, first obtained by audacious extrapolation, has been
backed up by more recent studies [91].
In 2000, Casrouge et al. [92] analysed mouse spleens [93].
The same mathematical extrapolation as that just described,
from the subset of VB10, VJ1.2 cells with 10-amino-acid-
long CDR3, yielded an estimate of half a million distinct
TCRb chains. They also estimated that the combination
with the TCRa chain contributes a factor of more than two
to the diversity, thus concluding that a mouse spleen contains
about 106 clones of about 10 cells each. In mice, different
T-cell subsets can be compared, and the effects of infections
and immunization on the repertoire can be tracked [94–97].
Current single-cell approaches [98] are able to provide infor-
mation about the promiscuity of the ab pairing, which is
needed to establish the true extent of TCR clonal diversity.
Freeman et al. [99] identified 33 664 distinct TCRb
sequences in a pool of cells from 550 people. Recent studies,
which were able to directly count large numbers of
sequences, have identified 106 distinct TCRb chains in a
sample of blood from one person. It is possible to use ecologi-
cal ‘missing species’ analyses [100–102] to estimate the total
number of distinct TCRb chains in the blood. Estimates
range from a few million to as high as 100 million
[100,101,103]. Li et al. [104] isolated PBMCs and extracted
genomic DNA from 10 ml of blood from two rhesusmonkeys. They identified nearly a quarter of a million
unique CDR3 amino acid sequences in the sample.
Counting experimentally the total number of distinct TCRs
in a body may never be possible, but even if it becomes poss-
ible, it will not fully characterize the T-cell repertoire, i.e. the
number of cells of each clone. In fact, (deep) sequencing
does not provide a direct measurement of the distribution of
values of ni, because the number of times a sequence is
found depends on mRNA copy numbers inside cells and on
biases in PCR amplification [105]. Sequencing one cell at a
time is an attractive alternative, but is currently limited in prac-
tice to a few hundred cells per experiment. Computational
models, on the other hand, are rapid and cheap and may pro-
vide the only alternative to properly quantify the distribution
of clonotype sizes. Here, at least two approaches are possible:
(i) using statistical models to compare distributions and define
observables and (ii) developing mechanistic models of cell div-
ision and death to establish what parameters influence the
steady-state distribution of clonotype sizes. For example, in
the first approach, we could define three ways of allocating
107 cells (of a mouse) into the estimated 106 different clono-
types [92], as illustrated in figure 1. We could then take
samples of 2000 cells from each distribution, to replicate an
experimental protocol, and compare the resulting histograms
from experimental data and the computational model. In the
case shown, most of the TCRs that are present in a sample
are found only once. The presence of two or more cells of
the same TCR clonotype in such a sample is evidence
that there are clonotypes with large numbers of cells in the
repertoire (e.g. expanded in response to antigen).
Whatever statistically stationary set of ni(t) is compatible
with human (or mouse) experiments results from a balance
between T-cell generation (in the thymus), division and
DP1
x1
x12f x23
x24 x38
x2
y4 y8
x3
m1 m2
n4 n8
m3
DP2
CD4+ SP CD8+ SP
DP3
Figure 2. Mathematical model of thymocyte development as introduced and developed in Sinclair et al. [111]. Thymocytes enter the DP1 stage from DN cells with
influx f. At the DP1 stage, thymocytes can either die with rate m1 or differentiate to the DP2 stage with rate j12. At the DP2 stage, thymocytes can either die with
rate m2, or differentiate to the DP3 stage with rate j23, or to the SP CD4
þ stage with rate j24. DP3 thymocytes can either die with rate m3 or differentiate to the SP
CD8þ stage with rate j38. CD4
þ SP thymocytes die or exit to the periphery with a total loss rate n4, and CD8
þ SP do so with rate n8. (Online version in colour.)
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cell population, in which the ni(t) are functions of time, gov-
erned by thymic production of new T-cell clonotypes, and
division and death of existing cells in the periphery have
been proposed [106–110]. Often these models simulate eco-
logical competition within and among clones for TCR
signals and other resources (e.g. IL7) to study what factors
are more important in determining the distribution of T-cell
clones. Moreover, using estimates for the basic processes (of
thymic generation, division and death) from human and
mice, the models allow comparison of predictions of the dis-
tribution of clonotypes in those two cases. One such model
predicts a much larger number of clonotypes than estimated
experimentally so far [110]. The model could be used to pro-
duce figures similar to figure 1 to start comparing the
predictions with the data, and if needed the model could
be refined to better describe experimental data. In summary,
as well as requiring statistical models to deduce the size of
the T-cell repertoire from experimental measurements, math-
ematical modelling is needed to understand how homeostasis
of that repertoire is attained and maintained.4.2. Quantifying thymic development of T cells
A beautiful example of how experimental data together with
a mathematical model allows us to quantify immunological
processes is provided in [111]. This paper provides an excel-
lent lesson on the role that modelling can play in quantifying
immunological process; in doing so, new light is shed into the
mechanisms that are at the heart of the given immunological
process.
Cells of the mature ab T-cell repertoire arise from the
development in the thymus of bone marrow precursors (or
thymocytes). ab T-cell maturation is characterized by the
expression of thousands of copies of identical ab TCRs and
the CD4 and/or CD8 co-receptors on the surface ofthymocytes. The overall maturation stages of a thymocyte
are (i) double negative (DN) (TCR2, CD42 and CD82),
(ii) double positive (DP) (TCRþ, CD4þ and CD8þ), and
(iii) single positive (SP) (TCRþ, CD4þ or CD8þ). Thymic
APCs provide the appropriate microarchitecture for the
maturation of thymocytes, which ‘sense’ the signalling
environment via their randomly generated TCRs. Naive
CD4þ and CD8þ T cells that populate the immune system
derive, thus, from the SP CD4þ and CD8þ thymocytes,
respectively, that were successfully selected and exited the
thymus into the periphery. The observed ratio of naive
CD4þ to CD8þ T cells is about 2 : 1; that is, there are more
CD4þ helper T cells than CD8þ cytotoxic T cells in the periph-
eral pool [81,112]. A long-standing immunological question is
the origin of this asymmetry in CD4þ and CD8þ T-cell num-
bers and, in this paper, the authors set out to study thymic
development in search for clues to this bias [111].
Their approach combines a carefully designed experimental
study and a mathematical model that allows them to quantify
differentiation and death rates of different subsets of thymo-
cytes during their development (figure 2). Their results are
not only the estimation of these parameters, but also the ability
to discriminate between two hypotheses for the observed asym-
metry inCD4þ andCD8þT-cell numbers. The authors set out to
answer the question: what is the source of the asymmetry
between the CD4þ and CD8þ T-cell lineages during thymic
development? The experimental study is based on their ability
to synchronize cohorts of thymocytes in vivo to follow their kin-
etics as they develop and are being selected. The mathematical
model is based on a set of deterministic ordinary differential
equations that describe the dynamics of the thymocyte popu-
lations from the DP stage (figure 2). The model includes five
populations (DP1, DP2, DP3, CD4þ SP and CD8þ SP), where
the DP population is subdivided into three distinct temporal
stages of development (DP1, DP2 and DP3), which had pre-
viously been experimentally identified based on the surface
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also includes the rates of maturation from one stage to the next
( j12, j23, j24 and j38), and loss (n4 and n8) or death (m1,m2 andm3).
Loss is used to jointly describe death ormigration in the SP thy-
mocyte compartments. A migration term is included, f, to
represent the influx of cells into the DP1 stage fromDN thymo-
cytes. Finally, the mathematical model does not include cell
proliferation as recent estimates suggest that there is no prolifer-
ationduring theDPstage, andatmost one roundofproliferation
during the SP stage [111,114].
Quantifying and deciphering the mechanisms/sources of
asymmetry is a big challenge! At least two different hypoth-
eses can explain the thymic origin of the bias:
— at the DP1 stage, there is an asymmetry in the number of
DP thymocytes with a TCR that can bind to MHC class I
versus MHC class II, or
— during the DP or SP stage, there exists some asymmetry in
either maturation or loss processes (migration to the
periphery or death).
Three sets of experiments are carried out to identify the
source of the CD4/CD8 bias [111]. The first (or control)
experimental assay arrests thymic maturation at the DP
stage to then switch it on, and thus T-cell development can
be followed during 10 days in a synchronized way. Cell num-
bers were analysed with flow cytometry at days 0, 1, 2, 3, 4, 5,
6, 7, 8, 9 and 10. The second experimental assay is exactly as
the first, but with MHC class-I-deficient mice, so that only
CD4þ T cells can be selected. Finally, the third experimental
assay is performed, with MHC class-II-deficient mice, so
that only CD8þ T cells can be selected. In this way, the
authors can simultaneously and independently study
the development of CD4þ and CD8þ T cells. That is, the
experiments with deficient mice allow them to understand
lineage-specific maturation and death rates from the DP2
stage under conditions of isolated development.
Given the experimental data and the mathematical model,
the authors obtain estimates for the parameters of the model.
The most striking differences appear in the DP2 compart-
ment. For example, for the control experiments, they
estimate j24 ¼ 0.14 per day and j23 ¼ 0.07 per day, whereas
for the MHC class-I-deficient case mð4Þ2 ¼ 0:28 per day and
j
ð4Þ
24 ¼ 0:21 per day, and for the MHC class-II-deficient case
m
ð8Þ
2 ¼ 0:88 per day and jð8Þ23 ¼ 0:20.2 This indicates that a
source of asymmetry is the difference in death for the CD4þ
and CD8þ thymocytes at the DP2 stage. It is at the DP
stage when the commitment to either CD4þ or CD8þ lineage
is decided. Furthermore, they introduce the dimensionless
parameter s, or selection efficiency, for any of the DP com-
partments as the ratio between the maturation rate and the
sum of the maturation and death rates. For example, for
DP2 thymocytes in the case of MHC class-I-deficient T-cell
development, the selection efficiency is given by
s4 ¼ j
ð4Þ
24
j
ð4Þ
24 þ mð4Þ2
¼ 0:21
0:21þ 0:28 ¼ 0:43: ð4:1Þ
In the case of MHC class-II-deficient T-cell development,
the selection efficiency is given by
s8 ¼ j
ð8Þ
23
j
ð8Þ
23 þ mð8Þ2
¼ 0:20
0:20þ 0:88 ¼ 0:19: ð4:2ÞThus, not only is the CD8þ lineage at a disadvantage in terms
of death rates during the DP2 stage, but also the selection effi-
ciency is lower than that of the CD4þ lineage. On the other
hand, at the DP1 stage, no significant differences are
observed between the death m1 and maturation rates j12 esti-
mated for the three different experimental conditions: control,
MHC class-I- and MHC class-II-deficient mice.
Taken together, experimental observations and parameter
estimates for MHC-deficient mice, the authors can identify
that the source of CD4 enrichment takes place at the DP2
stage, given the differences in both death rates and selection
efficiencies. Thus, one can now discriminate between the two
hypotheses, as the data and the quantification do not support
a greater abundance of MHC class-II-restricted thymocytes
than MHC class I at the DP1 stage (first hypothesis).5. Reconciling experimental results
5.1. Quantifying T-cell proliferation
HIV-1 infection results in depletion of CD4þ T cells, but it is
not clear what dynamical processes are responsible for this
cell loss. One hypothesis is that reduced production from the
thymus (see §3.1) causes a decline in cell numbers. Other pos-
sibilities are changes in proliferation and death rates of CD4þ T
cells. Several clever experimental assays have been developed
to analyse proliferation rates of T cells in humans, allowing
comparison of healthy and HIVþ individuals.
One of the first measurements of CD4þ and CD8þ T-cell
proliferation was based on the length of their respective telo-
meres. These are segments of repeated nucleotide sequences
at the end of chromosomes, which protect them during repli-
cation, because copying of the DNA cannot proceed to the
very end of the molecule, since the copying enzymes fall
off. Thus, at every cell division, chromosomes lose some
nucleotides at the end and, without telomeres, information
would be lost (i.e. genes could be truncated). Proliferation
of T cells (and others) leads to shortening of the telomeres.
Wolthers et al. [115] used this idea and measured telomere
length over time (up to 10 years) in healthy and HIV-infected
individuals, in both their CD4þ and CD8þ T cells. They found
stable telomeres in both subsets of healthy people, whereas in
HIV-infected people there was no change in the length of tel-
omeres in CD4þ T cells, but a large decrease in this length in
CD8þ T cells. This was interpreted as providing ‘evidence
that turnover in the course of HIV-1 infection can be
increased considerably in CD8þ T cells, but not in CD4þ T
cells’ [115].
A second method to assess T-cell proliferation is based on
the expression of the Ki-67 antigen, which is a protein expressed
only during cell division. Thus measuring the fraction of T cells
bearing this antigen gives a snapshot of the proliferative state of
these cells. Analyses of this marker showed that both popu-
lations of CD4þ and CD8þ T cells have increased expression
ofKi-67 inHIV-1 infection comparedwith healthy age-matched
controls [116].Although therewas largeperson-to-personvaria-
bility, therewas a significant correlation between the fractions of
Ki-67þCD4þT cells andKi-67þCD8þT cells, aswell as between
Ki-67þ CD4þ T cells and HIV-1 viral load in infected people,
indicating that both CD4þ and CD8þ T-cell subsets have
increased turnover in the setting of HIV-1 infection [116].
These results were confirmed and extended in another study
that analysed Ki-67 expression before and after antiretroviral
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Figure 3. Model used to analyse deuterated glucose labelling of dividing T cells. (a) Schematic of the model showing the populations of resting and dividing cells,
their interconversion (activation, a, and reversion, r), proliferation ( p) and death (d ) of dividing cells. (b) Example of model fit to data for the labelling of cells in one
HIV-1-infected person before therapy (diamonds), after short-term therapy (triangles) and long-term therapy (circles). Therapy leads to lower label incorporation,
indicating slower turnover; however, if one measures incorporation only after 20–25 days (dashed grey box), there are higher levels of labelling after long-term
treatment, which would suggest elevated turnover. The model clearly shows that it is the slope of incorporation or loss of label that contains the relevant
information about turnover, not the labelling level at any one time.
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was proliferation increased in relation to healthy controls, but
this proliferation also declined rapidly with the initiation of
treatment [117].
In part, because the methods described are indirect and,
in part, because there were relevant discrepancies among
the results, a direct measurement of T-cell turnover was
applied in the context of HIV-1 infection [118]. This method
is based on infusion of deuterated glucose (i.e. glucose
where hydrogen has been partly replaced by deuterium) to
volunteers. This deuterated glucose will be incorporated in
newly synthesized DNA of proliferating cells, in effect label-
ling them. Sampling T cells from blood after infusion and
measuring the fraction of cells labelled with deuterated glu-
cose allows the quantification of T-cell turnover. However,
even this ‘direct measurement’ needs some mathematical
model to correctly interpret the labelling data. In the first
study of HIV-1 infection using this technique, with a 2-day
infusion of deuterated glucose, the increase in proliferation
of both CD4þ and CD8þ T cells during HIV-1 infection was
confirmed, but, surprisingly, it was found that both prolifer-
ation rates were even more increased during successful
therapy (i.e. suppressing viral load below detection) [118].
Altogether, these experimental studies resulted in contra-
dictory conclusions, which is a good indication that a
modelling approach can be very useful. Initial modelling
results suggested that a longer infusion of deuterated glu-
cose, leading to higher T-cell-labelled fractions, together
with time courses of labelling, would be more informative.
A study was devised with 7-day continuous infusion of deut-
erated glucose, followed by sampling up to six weeks post-
infusion [119]. These data were analysed with a new model
allowing for cell activation, proliferation and death (rep-
resented in figure 3) [120]. The equations for the resting
cells, R, and activated cells, A, are
dR
dt
¼ aRþ rA ð5:1Þ
and
dA
dt
¼ ðp dÞAþ a0R rA, ð5:2Þwhere a is the activation rate from a compartment of truly
resting cells (with an allowance for clonal activation, hence
the a0), r is the rate of return to rest from the activated
(dividing) state, and p and d are the proliferation and
death rates of activated (dividing) cells, respectively (a
full analysis of the model is provided in [121]). With the
help of this model, it was established that proliferation of
both CD4þ and CD8þ T cells was increased during HIV-
1 infection, and it quickly reduced after the initiation of
antiretroviral treatment [119,120]. The estimates of prolifer-
ation from the model were highly correlated with Ki-67þ
fractions in both CD4þ and CD8þ T cells. Moreover, the
model indicated that activation, proliferation and death of
CD4þ T cells was increased, thus leading to stable or
lower numbers of proliferating cells over time. On the
other hand, in the CD8þ T-cell pool, the increased prolifer-
ation leads to larger numbers of proliferating cells [120].
These modelling results explained the telomere data:
although CD4þ T cells have higher proliferation rates,
these proliferating cells also die quickly leaving behind
cells that have proliferated less, with closer to normal telo-
mere lengths; on the other hand, proliferating CD8þ T cells
accumulate resulting in shorter telomeres. (This possibility
had already been raised by modelling of proliferation and
telomere shortening [122].) In addition these models of
deuterated glucose showed that, to estimate proliferation,
it is important to analyse the slopes of label uptake and
loss [120], rather than just the level of labelled cells at
one time point [118] (figure 3).
Modelling, thus, contributed to reconcile disparate,
even contradictory, results of different techniques to
measure T-cell proliferation. At the same time, these initial
models also suggested that analyses of this type of data
may be more complex than originally thought. For
example, one assumes that all cells are proliferating at
the same average rate, although it is more likely that
different subpopulations have different proliferation rates
and/or that these change over time. This has led to
numerous studies, of both modelling [79,123–128] and
experimental [129–132] aspects, related to T-cell prolifer-
ation (an excellent recent review on the subject is
provided in [133]).
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Here, we have focused on examples based on T-cell immu-
nology at the level of populations of cells to maintain a
unifying theme. However, many studies from other areas of
immunology would also illustrate the richness of mathematical
contributions to developing insight into physiological processes.
Mathematical and computational models have also been suc-
cessful in humoral [134,135] and innate immunity [136,137].
The recent discovery of de facto innate immune memory
[138,139], and of properties of tissue-resident memory T cells,
reminiscent of those of innate immune cells [140], are provoking
a rethink of the divisions between subfields of immunology,
more in tune with the mathematician’s natural urge to unite
descriptions of the symphonies of molecular and cellular inter-
actions by identifying what is essential.
These examples are often driven by technical advances in
genomics, proteomics, mRNA quantification, single-cell
capabilities and others, demonstrating how novel experimental
approaches push model development. Indeed, new modelling
approaches are also needed to make use of the complexity of
the data generated [141–144]. It is important to note that these
models span multiple biological scales, including intracellular
and molecular levels [8,145,146]. Obviously, good mathematical
models need good quantitative data, and this is often harder to
obtain at finer scales, such as the molecular level. Future techno-
logical developments will bring new challenges for modellers.
In spite of these beautiful studies, collaborations between
mathematical and experimental immunologists are still infre-
quent. These collaborations are a fertile ground for new ideas
and primed for great impact; however, there are challenges
that need to be taken into consideration as the field moves
forward. One shared feature of emergent fields is the hetero-
geneity of approaches, methods and available data. In this
context, a certain level of standardization could be helpful
to facilitate reproducibility and model sharing and to
reduce publication errors by means, for example, of
language-independent model definition, with repositories of
models contributed by the community. There are several
such repositories, such as CellML [147], which is a free,
open-source, extensible markup language-based standard
for defining mathematical models of cellular function. It cur-
rently incorporates more than 50 models in the broad area of
mathematical immunology. Other examples are systemsbiology markup language [148] and JSim [149], which
allows storage of data and model analysis.
Recent technical advances permit single-cell measurements
[150–152], revealing the inherent heterogeneity in immuno-
logical processes. Single-cell data interpretation is almost
impossible without mathematics. To realize the full promise
of mathematical immunology, more and stronger collabor-
ations between modellers and experimental scientists are
needed. One way to stimulate these is to provide venues for
enhanced interactions among scientists, at international meet-
ings such as Systems Approaches in Immunology, q-Bio
conferences, the KITP Quantitative Immunology programmes,
HIV Dynamics and Evolution Conference and collaborative
networks such as QuanTI [153], ENLIGHT-TEN [154],
INDOEUROPEAN-MATHDS [155] and INTI [156].
In conclusion, it is possible to find excellent examples of
synergy between modelling and experiment in immunology,
but still much remains to be done.
Author’s contribution. All authors contributed equally to the ideas and
writing of this article.
Competing interests. We declare we have no competing interests.
Funding. This work has been partially supported by grants BBSRC BB/
F003811/1 (G.L., C.M.P.), BBSRC BB/G023395/1 (C.M.P.), FIS2013–
47949-C2-2-P (M.C., G.L., C.M.P.), PIRSES-GA-2012-317893 (M.C.,
G.L., C.M.P.) and National Institutes of Health grant no. R01-
AI104373 (R.M.R.). This work has been possible with travel support
from the EU, via the FP7 IRSES Network INDOEUROPEAN-
MATHDS: Mathematics for health and disease.
Acknowledgements. M.C., G.L. and C.M.P. thank Los Alamos National
Laboratory and the University of New Mexico for their hospitality
during the drafting and writing of this manuscript. The authors thank
Stig Omholt and Peter Hunter for feedback on preliminary versions
of this manuscript, as well as two anonymous reviewers, whose
comments helped to substantially improve the manuscript.
Disclaimer. The content is solely the responsibility of the authors and does
not necessarily represent the official views of funding organizations.Endnotes
1This is in agreement and consistent with other single-cell tracking
studies [52].
2The superscript, (4) or (8), in a given parameter indicates that it has
been estimated making use of MHC class-I- or MHC class-II-deficient
mice data, respectively.References1. Baltzer F. 1964 Theodor Boveri. Science
144, 809–815. (doi:10.1126/science.144.3620.809)
2. BMC Biology. 2014 Beyond Mendel: modeling in
biology. See http://www.biomedcentral.com/
bmcbiol/series/beyondmendel.
3. Callard RE, Yates AJ. 2005 Immunology
and mathematics: crossing the divide.
Immunology 115, 21–33. (doi:10.1111/j.1365-
2567.2005.02142.x)
4. Lander AD. 2014 Making sense in biology: an
appreciation of Julian Lewis. BMC Biol. 12, 57.
(doi:10.1186/s12915-014-0057-5)
5. Noble D. 2002 The rise of computational biology. Nat.
Rev. Mol. Cell Biol. 3, 459–463. (doi:10.1038/nrm810)6. Germain RN. 2004 An innately interesting decade of
research in immunology. Nat. Med. 10, 1307–1320.
(doi:10.1038/nm1159)
7. Chakraborty AK, Das J. 2010 Pairing
computation with experimentation: a
powerful coupling for understanding T cell
signalling. Nat. Rev. Immunol. 10, 59–71. (doi:10.
1038/nri2688)
8. Altan-Bonnet G, Germain RN. 2005 Modeling T cell
antigen discrimination based on feedback control of
digital ERK responses. PLoS Biol. 3, e356. (doi:10.
1371/journal.pbio.0030356)
9. Germain RN, Meier-Schellersheim M, Nita-Lazar A,
Fraser ID. 2011 Systems biology in immunology—acomputational modeling perspective. Annu. Rev.
Immunol. 29, 527–585. (doi:10.1146/annurev-
immunol-030409-101317)
10. Rochman Y, Spolski R, Leonard WJ. 2009 New
insights into the regulation of T cells by c family
cytokines. Nat. Rev. Immunol. 9, 480–490. (doi:10.
1038/nri2580)
11. Hunter PJ, Borg TK. 2003 Integration from
proteins to organs: the Physiome project. Nat.
Rev. Mol. Cell Biol. 4, 237–243. (doi:10.1038/
nrm1054)
12. Arazi A, Pendergraft WF, Ribeiro RM, Perelson AS,
Hacohen N. 2013 Human systems immunology:
hypothesis-based modeling and unbiased data-
rsfs.royalsocietypublishing.org
Interface
Focus
6:20150093
11
 on April 15, 2016http://rsfs.royalsocietypublishing.org/Downloaded from driven approaches. Semin. Immunol. 25, 193–200.
(doi:10.1016/j.smim.2012.11.003)
13. Gunawardena J. 2014 Models in biology: ‘accurate
descriptions of our pathetic thinking’. BMC Biol. 12,
29. (doi:10.1186/1741-7007-12-29)
14. Molina-Par´ıs C, Lythe G. 2011 Mathematical models
and immune cell biology. New York, NY: Springer
Science and Business Media.
15. Tauber AI, Podolsky SH. 2000 The generation of
diversity: clonal selection theory and the rise of
molecular immunology. Cambridge, MA: Harvard
University Press.
16. Dobzhansky T. 1964 Biology, molecular and
organismic. Am. Zool. 4, 443–452. (doi:10.1093/
icb/4.4.443)
17. Cyster JG. 1999 Chemokines and cell migration in
secondary lymphoid organs. Science 286, 2098–
2102. (doi:10.1126/science.286.5447.2098)
18. Bajenoff M, Egen J, Qi H, Huang A, Castellino F,
Germain R. 2007 Highways, byways and
breadcrumbs: directing lymphocyte traffic in the
lymph node. Trends Immunol. 28, 346–352.
(doi:10.1016/j.it.2007.06.005)
19. Miller MJ, Wei SH, Parker I, Cahalan MD. 2002 Two-
photon imaging of lymphocyte motility and antigen
response in intact lymph node. Science 296, 1869–
1873. (doi:10.1126/science.1070051)
20. Stoll S, Delon J, Brotz TM, Germain RN. 2002
Dynamic imaging of T cell-dendritic cell interactions
in lymph nodes. Science 296, 1873–1876. (doi:10.
1126/science.1071065)
21. Bousso P, Bhakta NR, Lewis RS, Robey E. 2002
Dynamics of thymocyte-stromal cell
interactions visualized by two photon microscopy.
Science 296, 1876–1880. (doi:10.1126/science.
1070945)
22. Germain RN, Robey EA, Cahalan MD. 2012 A decade
of imaging cellular motility and interaction
dynamics in the immune system. Science 336,
1676–1681. (doi:10.1126/science.1221063)
23. Moreau HD, Bousso P. 2014 Visualizing how T cells
collect activation signals in vivo. Curr. Opin.
Immunol. 26, 56–62. (doi:10.1016/j.coi.2013.10.
013)
24. Zinselmeyer BH et al. 2005 In situ characterization
of CD4þ T cell behavior in mucosal and systemic
lymphoid tissues during the induction of oral
priming and tolerance. J. Exp. Med. 201, 1815–
1823. (doi:10.1084/jem.20050203)
25. Cahalan MD, Parker I, Wei SH, Miller MJ. 2003 Real-
time imaging of lymphocytes in vivo. Curr. Opin.
Immunol. 15, 372–377. (doi:10.1016/S0952-
7915(03)00079-7)
26. Beltman JB, Mar´ee AF, de Boer RJ. 2009 Analysing
immune cell migration. Nat. Rev. Immunol. 9, 789–
798. (doi:10.1038/nri2638)
27. Preston S, Waters S, Jensen O, Heaton P, Pritchard
D. 2006 T-cell motility in the early stages of the
immune response modeled as a random walk
amongst targets. Phys. Rev. E 74, 11910. (doi:10.
1103/PhysRevE.74.011910)
28. Meyer-Hermann ME, Maini PK. 2005 Interpreting
two-photon imaging data of lymphocyte motility.Phys. Rev. E 71, 61912. (doi:10.1103/PhysRevE.71.
061912)
29. Beauchemin C, Dixit NM, Perelson AS. 2007
Characterizing T cell movement within lymph nodes
in the absence of antigen. J. Immunol. 178, 5505–
5512. (doi:10.4049/jimmunol.178.9.5505)
30. Textor J, Henrickson SE, Mandl JN, von Andrian UH,
Westermann J, de Boer RJ, Beltman JB. 2014
Random migration and signal integration promote
rapid and robust T cell recruitment. PLoS Comput.
Biol. 10, e1003752. (doi:10.1371/journal.pcbi.
1003752)
31. Mandl JN, Liou R, Klauschen F, Vrisekoop N,
Monteiro JP, Yates AJ, Huang AY, Germain RN. 2012
Quantification of lymph node transit times reveals
differences in antigen surveillance strategies of
naive CD4þ and CD8þ T cells. Proc. Natl Acad. Sci.
USA 109, 18 036–18 041. (doi:10.1073/pnas.
1211717109)
32. Letendre K, Donnadieu E, Moses ME, Cannon JL.
2015 Bringing statistics up to speed with data in
analysis of lymphocyte motility. PLoS ONE 10,
e1026333. (doi:10.1371/journal.pone.0126333)
33. Baj´enoff M, Egen JG, Koo LY, Laugier JP, Brau F,
Glaichenhaus N, Germain RN. 2006 Stromal cell
networks regulate lymphocyte entry, migration,
and territoriality in lymph nodes.
Immunity 25, 989–1001. (doi:10.1016/j.immuni.
2006.10.011)
34. Mueller SN, Germain RN. 2009 Stromal cell
contributions to the homeostasis and functionality
of the immune system. Nat. Rev. Immunol. 9, 618–
629. (doi:10.1038/nri2588)
35. Donovan GM, Lythe G. 2012 T-cell movement on
the reticular network. J. Theor. Biol. 295, 59–67.
(doi:10.1016/j.jtbi.2011.11.001)
36. Graw F, Regoes RR. 2012 Influence of the
fibroblastic reticular network on cell-cell interactions
in lymphoid organs. PLoS Comput. Biol. 8,
e1002436. (doi:10.1371/journal.pcbi.1002436)
37. Vroomans RM, Mar´ee AF, de Boer RJ, Beltman JB.
2012 Chemotactic migration of T cells towards
dendritic cells promotes the detection of rare
antigens. PLoS Comput. Biol. 8, e1002763. (doi:10.
1371/journal.pcbi.1002763)
38. Celli S, Day M, Mu¨ller AJ, Molina-Paris C, Lythe G,
Bousso P. 2012 How many dendritic cells are
required to initiate a T-cell response? Blood 120,
3945–3948. (doi:10.1182/blood-2012-01-408260)
39. Ariotti S, Hogenbirk MA, Dijkgraaf FE, Visser LL,
Hoekstra ME, Song JY, Jacobs H, Haanen JB,
Schumacher TN. 2014 Skin-resident memory CD8þ T
cells trigger a state of tissue-wide pathogen alert.
Science 346, 101–105. (doi:10.1126/science.1254803)
40. Ariotti S et al. 2012 Tissue-resident memory CD8þ
T cells continuously patrol skin epithelia to
quickly recognize local antigen. Proc. Natl Acad. Sci.
USA 109, 19 739–19 744. (doi:10.1073/pnas.
1208927109)
41. Ariotti S, Beltman JB, Borsje R, Hoekstra ME, Halford
WP, Haanen JB, de Boer RJ, Schumacher TNM. 2015
Subtle CXCR3-dependent chemotaxis of CTLs within
infected tissue allows efficient target localization.J. Immunol. 195, 5285–5295. (doi:10.4049/
jimmunol.1500853)
42. Bousso P, Robey EA. 2004 Dynamic behavior of T
cells and thymocytes in lymphoid organs as
revealed by two-photon microscopy. Immunity 21,
349–355. (doi:10.1016/j.immuni.2004.08.005)
43. Mempel TR, Henrickson SE, Von Andrian UH. 2004
T-cell priming by dendritic cells in lymph nodes
occurs in three distinct phases. Nature 427,
154–159. (doi:10.1038/nature02238)
44. Beltman JB, Mar´ee AF, Lynch JN, Miller MJ, de Boer
RJ. 2007 Lymph node topology dictates T cell
migration behavior. J. Exp. Med. 204, 771–780.
(doi:10.1084/jem.20061278)
45. Bogle G, Dunbar PR. 2009 Agent-based simulation
of T-cell activation and proliferation within a lymph
node. Immunol. Cell Biol. 88, 172–179. (doi:10.
1038/icb.2009.78)
46. Graner F, Glazier JA. 1992 Simulation of biological
cell sorting using a two-dimensional extended Potts
model. Phys. Rev. Lett. 69, 2013. (doi:10.1103/
PhysRevLett.69.2013)
47. Glazier JA, Graner F. 1993 Simulation of the
differential adhesion driven rearrangement of
biological cells. Phys. Rev. E 47, 2128. (doi:10.1103/
PhysRevE.47.2128)
48. Beltman JB, Mar´ee AF, De Boer RJ. 2007 Spatial
modelling of brief and long interactions between T
cells and dendritic cells. Immunol. Cell Biol. 85,
306–314. (doi:10.1038/sj.icb.7100054)
49. Coombs D, Kalergis AM, Nathenson SG, Wofsy C,
Goldstein B. 2002 Activated TCRs remain marked for
internalization after dissociation from pMHC. Nat.
Immunol. 3, 926–931. (doi:10.1038/ni838)
50. Dushek O, Das R, Coombs D. 2009 A role for
rebinding in rapid and reliable T cell responses to
antigen. PLoS Comput. Biol. 5, e1000578. (doi:10.
1371/journal.pcbi.1000578)
51. Aleksic M, Dushek O, Zhang H, Shenderov E, Chen
JL, Cerundolo V, Coombs D, van der Merwe PA.
2010 Dependence of T cell antigen recognition on T
cell receptor-peptide MHC confinement time.
Immunity 32, 163–174. (doi:10.1016/j.immuni.
2009.11.013)
52. Marchingo JM et al. 2014 Antigen affinity,
costimulation, and cytokine inputs sum linearly to
amplify T cell expansion. Science 346, 1123–1127.
(doi:10.1126/science.1260044)
53. Hawkins ED, Turner ML, Dowling MR, Van Gend C,
Hodgkin PD. 2007 A model of immune regulation
as a consequence of randomized lymphocyte
division and death times. Proc. Natl Acad. Sci. USA
104, 5032–5037. (doi:10.1073/pnas.0700026104)
54. Turner ML, Hawkins ED, Hodgkin PD. 2008
Quantitative regulation of B cell division destiny by
signal strength. J. Immunol. 181, 374–382. (doi:10.
4049/jimmunol.181.1.374)
55. Hawkins E, Markham J, McGuinness L, Hodgkin P.
2009 A single-cell pedigree analysis of alternative
stochastic lymphocyte fates. Proc. Natl Acad. Sci. USA
106, 13 457–13 462. (doi:10.1073/pnas.0905629106)
56. Subramanian VG, Duffy KR, Turner ML, Hodgkin PD.
2008 Determining the expected variability of
rsfs.royalsocietypublishing.org
Interface
Focus
6:20150093
12
 on April 15, 2016http://rsfs.royalsocietypublishing.org/Downloaded from immune responses using the cyton model.
J. Math. Biol. 56, 861–892. (doi:10.1007/s00285-
007-0142-2)
57. Hawkins ED, Turner ML, Wellard CJ, Zhou J, Dowling
MR, Hodgkin P. 2013 Quantal and graded
stimulation of B lymphocytes as alternative
strategies for regulating adaptive immune
responses. Nat. Commun. 4, 2406. (doi:10.1038/
ncomms3406)
58. Sakaue-Sawano A et al. 2008 Visualizing
spatiotemporal dynamics of multicellular cell-cycle
progression. Cell 132, 487–498. (doi:10.1016/j.cell.
2007.12.033)
59. Mechali M, Lutzmann M. 2008 The cell cycle: now
live and in color. Cell 132, 341–343. (doi:10.1016/j.
cell.2008.01.031)
60. Sakaue-Sawano A, Miyawaki A. 2014 Visualizing
spatiotemporal dynamics of multicellular cell-cycle
progressions with fucci technology. Cold Spring
Harbour Protoc. 2014, pii: pdb.prot080408. (doi:10.
1101/pdb.prot080408)
61. Ribeiro RM, Perelson AS. 2007 Determining thymic
output quantitatively: using models to interpret
experimental T-cell receptor excision circle (TREC)
data. Immunol. Rev. 216, 21–34. (doi:10.1111/j.
1600-065X.2006.00493.x)
62. Kong F, Chen CH, Cooper MD. 1998 Thymic function
can be accurately monitored by the level of recent T
cell emigrants in the circulation. Immunity 8, 97–
104. (doi:10.1016/S1074-7613(00)80462-8)
63. Douek DC et al. 1998 Changes in thymic function
with age and during the treatment of HIV infection.
Nature 396, 690–695. (doi:10.1038/25374)
64. Kong FK, Chen CL, Six A, Hockett RD, Cooper MD.
1999 T cell receptor gene deletion circles identify
recent thymic emigrants in the peripheral T cell
pool. Proc. Natl Acad. Sci. USA 96, 1536–1540.
(doi:10.1073/pnas.96.4.1536)
65. Livak F, Schatz DG. 1996 T-cell receptor alpha locus
V(D)J recombination by-products are abundant in
thymocytes and mature T cells. Mol. Cell Biol. 16,
609–618. (doi:10.1128/MCB.16.2.609)
66. Guy-Grand D, Azogui O, Celli S, Darche S,
Nussenzweig MC, Kourilsky P, Vassalli P. 2003
Extrathymic T cell lymphopoiesis ontogeny and
contribution to gut intraepithelial lymphocytes in
athymic and euthymic mice. J. Exp. Med. 197,
333–341. (doi:10.1084/jem.20021639)
67. Verschuren MC, Wolvers-Tettero IL, Breit TM,
Noordzij J, van Wering ER, van Dongen JJ. 1997
Preferential rearrangements of the T cell receptor-
delta-deleting elements in human T cells.
J. Immunol. 158, 1208–1216.
68. Zhang L et al. 1999 Measuring recent thymic
emigrants in blood of normal and HIV-1-infected
individuals before and after effective therapy. J. Exp.
Med. 190, 725–732. (doi:10.1084/jem.190.5.725)
69. Hatzakis A et al. 2000 Effect of recent thymic
emigrants on progression of HIV-1 disease. Lancet
355, 599–604. (doi:10.1016/S0140-
6736(99)10311-8)
70. Ye P, Kirschner DE. 2002 Measuring emigration of
human thymocytes by T-cell receptor excisioncircles. Crit. Rev. Immunol. 22, 483–497. (doi:10.
1615/critrevimmunol.v22.i5-6.80)
71. Hazenberg MD, Borghans JA, de Boer RJ, Miedema
F. 2003 Thymic output: a bad TREC record. Nat.
Immunol. 4, 97–99. (doi:10.1038/ni0203-97)
72. Dion ML, Sekaly RP, Cheynier R. 2007 Estimating
thymic function through quantification of T-cell
receptor excision circles. Methods Mol. Biol. 380,
197–213. (doi:10.1007/978-1-59745-395-0_12)
73. Hazenberg MD et al. 2000 Increased cell division
but not thymic dysfunction rapidly affects the T-cell
receptor excision circle content of the naive T cell
population in HIV-1 infection. Nat. Med. 6, 1036–
1042. (doi:10.1038/79549)
74. Dutilh BE, de Boer RJ. 2003 Decline in excision
circles requires homeostatic renewal or homeostatic
death of naive T cells. J. Theor. Biol. 224, 351–358.
(doi:10.1016/S0022-5193(03)00172-3)
75. Lewin SR et al. 2002 Dynamics of T cells and TCR
excision circles differ after treatment of acute and
chronic HIV infection. J. Immunol. 169, 4657–4666.
(doi:10.4049/jimmunol.169.8.4657)
76. Carcelain G et al. 2003 IL-2 therapy and thymic
production of naive CD4T cells in HIV-infected
patients with severe CD4 lymphopenia. AIDS 17,
841–850. (doi:10.1097/00002030-200304110-
00009)
77. Di Mascio M et al. 2006 Naive T-cell dynamics in
human immunodeficiency virus type 1 infection:
effects of highly active antiretroviral therapy provide
insights into the mechanisms of naive T-cell
depletion. J. Virol. 80, 2665–2674. (doi:10.1128/
JVI.80.6.2665-2674.2006)
78. Ribeiro RM, de Boer RJ. 2008 The contribution of
the thymus to the recovery of peripheral naive T-cell
numbers during antiretroviral treatment for HIV
infection. J. Acquir. Immune Defic. Syndr. 49, 1–8.
(doi:10.1097/QAI.0b013e318184fb28)
79. Bains I, Thiebaut R, Yates AJ, Callard R. 2009
Quantifying thymic export: combining models of
naive T cell proliferation and TCR excision circle
dynamics gives an explicit measure of thymic
output. J. Immunol. 183, 4329–4336. (doi:10.4049/
jimmunol.0900743)
80. Ye P, Kirschner DE. 2002 Reevaluation of T cell
receptor excision circles as a measure of human
recent thymic emigrants. J. Immunol. 168, 4968–
4979. (doi:10.4049/jimmunol.168.10.4968)
81. Murray JM, Kaufmann GR, Hodgkin PD, Lewin SR,
Kelleher AD, Davenport MP, Zaunders JJ. 2003 Naive
T cells are maintained by thymic output in early
ages but by proliferation without phenotypic
change after age twenty. Immunol. Cell Biol. 81,
487–495. (doi:10.1046/j.1440-1711.2003.01191.x)
82. van den Dool C, de Boer RJ. 2006 The effects of age,
thymectomy, and HIV infection on alpha and beta
TCR excision circles in naive T cells. J. Immunol. 177,
4391–4401. (doi:10.4049/jimmunol.177.7.4391)
83. Arron ST et al. 2005 Impact of thymectomy on the
peripheral T cell pool in rhesus macaques before
and after infection with simian immunodeficiency
virus. Eur. J. Immunol. 35, 46–55. (doi:10.1002/eji.
200424996)84. Zarnitsyna V, Evavold B, Schoettle L, Blattman J,
Antia R. 2013 Estimating the diversity,
completeness, and crossreactivity of the T cell
repertoire. Front. Immunol. 4, 485. (doi:10.3389/
fimmu.2013.00485)
85. Robins H. 2013 Immunosequencing: applications of
immune repertoire deep sequencing. Curr. Opin.
Immunol. 25, 646–652. (doi:10.1016/j.coi.2013.09.
017)
86. Salameire D et al. 2009 Efficient characterization of
the TCR repertoire in lymph nodes by flow
cytometry. Cytometry Part A. 75, 743–751. (doi:10.
1002/cyto.a.20767)
87. Ciupe SM, Devlin BH, Markert ML, Kepler TB. 2013
Quantification of total T-cell receptor diversity by
flow cytometry and spectratyping. BMC Immunol.
14, 35. (doi:10.1186/1471-2172-14-35)
88. Britanova OV et al. 2014 Age-related decrease in
TCR repertoire diversity measured with deep
and normalized sequence profiling.
J. Immunol. 192, 2689–2698. (doi:10.4049/
jimmunol.1302064)
89. Elhanati Y, Murugan A, Callan CG, Mora T, Walczak
AM. 2014 Quantifying selection in immune receptor
repertoires. Proc. Natl Acad. Sci. USA 111, 9875–
9880. (doi:10.1073/pnas.1409572111)
90. Arstila TP, Casrouge A, Baron V, Even J,
Kanellopoulos J, Kourilsky P. 1999 A direct estimate
of the human ab T cell receptor diversity. Science
286, 958–961. (doi:10.1126/science.286.5441.958)
91. Baum PD, Young JJ, McCune JM. 2011
Measurement of absolute T cell receptor
rearrangement diversity. J. Immunol. Methods 368,
45–53. (doi:10.1016/j.jim.2011.03.001)
92. Casrouge A, Beaudoing E, Dalle S, Pannetier C,
Kanellopoulos J, Kourilsky P. 2000 Size estimate of
the ab TCR repertoire of naive mouse splenocytes.
J. Immunol. 164, 5782–5787. (doi:10.4049/
jimmunol.164.11.5782)
93. Bousso P, Levraud JP, Kourilsky P, Abastado JP. 1999
The composition of a primary T cell response is
largely determined by the timing of recruitment of
individual T cell clones. J. Exp. Med. 189, 1591–
1600. (doi:10.1084/jem.189.10.1591)
94. Bousso P, Casrouge A, Altman JD, Haury M,
Kanellopoulos J, Abastado JP, Kourilsky P. 1998
Individual variations in the murine T cell response
to a specific peptide reflect variability in naive
repertoires. Immunity 9, 169–178. (doi:10.1016/
S1074-7613(00)80599-3)
95. Venturi V, Kedzierska K, Tanaka MM, Turner SJ,
Doherty PC, Davenport MP. 2008 Method for
assessing the similarity between subsets of the T
cell receptor repertoire. J. Immunol. Methods 329,
67–80. (doi:10.1016/j.jim.2007.09.016)
96. Bergot AS, Chaara W, Ruggiero E, Mariotti-Ferrandiz
E, Dulauroy S, Schmidt M, Six A, Klatzmann D. 2015
TCR sequences and tissue distribution discriminate
the subsets of naive and activated/memory Treg
cells in mice. Eur. J. Immunol. 45, 1524–1534.
(doi:10.1002/eji.201445269)
97. Thomas N et al. 2014 Tracking global changes
induced in the CD4T cell receptor repertoire by
rsfs.royalsocietypublishing.org
Interface
Focus
6:20150093
13
 on April 15, 2016http://rsfs.royalsocietypublishing.org/Downloaded from immunization with a complex antigen using short
stretches of CDR3 protein sequence. Bioinformatics.
30, 3181–3188. (doi:10.1093/bioinformatics/
btu523)
98. Cukalac T, Kan WT, Dash P, Guan J, Quinn KM, Gras
S, Thomas PG, La Gruta NL. 2015 Paired TCRab
analysis of virus-specific CD8þ T cells exposes
diversity in a previously defined narrow
repertoire. Immunol. Cell Biol. 93, 804. (doi:10.
1038/icb.2015.44)
99. Freeman JD, Warren RL, Webb JR, Nelson BH, Holt
RA. 2009 Profiling the T-cell receptor beta-chain
repertoire by massively parallel sequencing. Genome
Res. 19, 1817–1824. (doi:10.1101/gr.092924.109)
100. Robins HS, Campregher PV, Srivastava SK, Wacher A,
Turtle CJ, Kahsai O, Riddell SR, Warren EH, Carlson
CS. 2009 Comprehensive assessment of T-cell
receptor b-chain diversity in ab T cells. Blood
114, 4099–4107. (doi:10.1182/blood-2009-04-
217604)
101. Warren RL, Freeman JD, Zeng T, Choe G, Munro S,
Moore R, Webb JR, Holt RA. 2011 Exhaustive T-cell
repertoire sequencing of human peripheral blood
samples reveals signatures of antigen selection and
a directly measured repertoire size of at least 1
million clonotypes. Genome Res. 21, 790–797.
(doi:10.1101/gr.115428.110)
102. Rempala GA, Seweryn M. 2013 Methods for
diversity and overlap analysis in T-cell receptor
populations. J. Math. Biol. 67, 1339–1368. (doi:10.
1007/s00285-012-0589-7)
103. Qi Q et al. 2014 Diversity and clonal selection in the
human T-cell repertoire. Proc. Natl Acad. Sci. USA
111, 13 139–13 144. (doi:10.1073/pnas.
1409155111)
104. Li Z et al. 2015 Comprehensive analysis of the T-cell
receptor beta chain gene in rhesus monkey by high
throughput sequencing. Sci. Rep. 5, 10092. (doi:10.
1038/srep10092)
105. Best K, Oakes T, Heather JM, Shawe-Taylor J, Chain
B. 2015 Computational analysis of stochastic
heterogeneity in PCR amplification efficiency
revealed by single molecule barcoding. Sci. Rep. 5.
(doi:10.1038/srep14629)
106. Antia R, Pilyugin SS, Ahmed R. 1998 Models of
immune memory: on the role of cross-reactive
stimulation, competition, and homeostasis in
maintaining immune memory. Proc. Natl Acad. Sci.
USA 95, 14 926–14 931. (doi:10.1073/pnas.95.25.
14926)
107. Stirk ER, Molina-Parı´s C, van den Berg HA. 2008
Stochastic niche structure and diversity maintenance
in the T cell repertoire. J. Theor. Biol. 255, 237–
249. (doi:10.1016/j.jtbi.2008.07.017)
108. Zilman A, Ganusov VV, Perelson AS. 2010 Stochastic
models of lymphocyte proliferation and death.
PLoS ONE 5, e12775. (doi:10.1371/journal.pone.
0012775)
109. Johnson PL, Yates AJ, Goronzy JJ, Antia R. 2012
Peripheral selection rather than thymic involution
explains sudden contraction in naive CD4 T-cell
diversity with age. Proc. Natl Acad. Sci. USA 109,
21 432–21 437. (doi:10.1073/pnas.1209283110)110. Lythe G, Callard RE, Hoare RL, Molina-Par´ıs C. 2016
How many TCR clonotypes does a body maintain?
J. Theor. Biol. 389, 214–224. (doi:10.1016/j.jtbi.
2015.10.016)
111. Sinclair C, Bains I, Yates AJ, Seddon B. 2013
Asymmetric thymocyte death underlies the CD4:
CD8 T-cell ratio in the adaptive immune system.
Proc. Natl Acad. Sci. USA 110, E2905–E2914.
(doi:10.1073/pnas.1304859110)
112. Comans-Bitter WM, de Groot R, van den Beemd R,
Neijens HJ, Hop WC, Groeneveld K, Hooijkaas H, van
Dongen JJM. 1997 Immunophenotyping of blood
lymphocytes in childhood: reference values for
lymphocyte subpopulations. J. Pediatr. 130,
388–393. (doi:10.1016/S0022-3476(97)70200-2)
113. Saini M, Sinclair C, Marshall D, Tolaini M, Sakaguchi
S, Seddon B. 2010 Regulation of Zap70 expression
during thymocyte development enables temporal
separation of CD4 and CD8 repertoire selection at
different signaling thresholds. Sci. Signal. 3, ra23.
(doi:10.1126/scisignal.2000702)
114. Stritesky GL, Xing Y, Erickson JR, Kalekar LA, Wang
X, Mueller DL, Jameson SC, Hogquist KA. 2013
Murine thymic selection quantified using a unique
method to capture deleted T cells. Proc. Natl Acad.
Sci. USA 110, 4679–4684. (doi:10.1073/pnas.
1217532110)
115. Wolthers KC et al. 1996 T cell telomere length in
HIV-1 infection: no evidence for increased CD4þ T
cell turnover. Science 274, 1543–1547. (doi:10.
1126/science.274.5292.1543)
116. Sachsenberg N et al. 1998 Turnover of CD4þ and
CD8þ T lymphocytes in HIV-1 infection as measured
by Ki-67 antigen. J. Exp. Med. 187, 1295–1303.
(doi:10.1084/jem.187.8.1295)
117. Hazenberg MD et al. 2000 T-cell division in human
immunodeficiency virus (HIV)-1 infection is mainly
due to immune activation: a longitudinal analysis in
patients before and during highly active
antiretroviral therapy (HAART). Blood 95, 249–255.
118. Hellerstein M et al. 1999 Directly measured kinetics
of circulating T lymphocytes in normal and HIV-1-
infected humans. Nat. Med. 5, 83–89. (doi:10.
1038/4772)
119. Mohri H et al. 2001 Increased turnover of T
lymphocytes in HIV-1 infection and its reduction by
antiretroviral therapy. J. Exp. Med. 194, 1277–
1287. (doi:10.1084/jem.194.9.1277)
120. Ribeiro RM, Mohri H, Ho DD, Perelson AS. 2002 In
vivo dynamics of T cell activation, proliferation, and
death in HIV-1 infection: why are CD4þ but not
CD8þ T cells depleted? Proc. Natl Acad. Sci. USA 99,
15 572–15 577. (doi:10.1073/pnas.242358099)
121. Ribeiro RM, Mohri H, Ho DD, Perelson AS. 2002
Modeling deuterated glucose labeling of T-
lymphocytes. Bull. Math. Biol. 64, 385–405.
(doi:10.1006/bulm.2001.0282)
122. Wolthers KC, Noest AJ, Otto SA, Miedema F, De Boer
RJ. 1999 Normal telomere lengths in naive and
memory CD4þ T cells in HIV type 1 infection: a
mathematical interpretation. AIDS Res. Hum.
Retroviruses 15, 1053–1062. (doi:10.1089/
088922299310340)123. Asquith B, Debacq C, Macallan DC, Willems L,
Bangham CR. 2002 Lymphocyte kinetics: the
interpretation of labelling data. Trends Immunol. 23,
596–601. (doi:10.1016/S1471-4906(02)02337-2)
124. De Boer RJ, Mohri H, Ho DD, Perelson AS. 2003
Turnover rates of B cells, T cells, and NK cells
in simian immunodeficiency virus-infected
and uninfected rhesus macaques. J. Immunol.
170, 2479–2487. (doi:10.4049/jimmunol.170.5.
2479)
125. Borghans JA, de Boer RJ. 2007 Quantification of T-
cell dynamics: from telomeres to DNA labeling.
Immunol. Rev. 216, 35–47. (doi:10.1111/j.1600-
065X.2007.00497.x)
126. Ganusov VV, Borghans JA, De Boer RJ. 2010 Explicit
kinetic heterogeneity: mathematical models for
interpretation of deuterium labeling of
heterogeneous cell populations. PLoS Comput. Biol.
6, e1000666. (doi:10.1371/journal.pcbi.1000666)
127. De Boer RJ, Perelson AS, Ribeiro RM. 2012
Modelling deuterium labelling of lymphocytes with
temporal and/or kinetic heterogeneity. J. R. Soc.
Interface 9, 2191–2200. (doi:10.1098/rsif.2012.
0149)
128. Ganusov VV, De Boer RJ. 2012 A mechanistic model
for bromodeoxyuridine dilution naturally explains
labelling data of self-renewing T cell populations.
J. R. Soc. Interface. 9, 20120617. (doi:10.1098/rsif.
2012.0617)
129. Hellerstein MK et al. 2003 Subpopulations of long-
lived and short-lived T cells in advanced HIV-1
infection. J. Clin. Invest. 112, 956–966. (doi:10.
1172/JCI200317533)
130. Vrisekoop N et al. 2008 Sparse production but
preferential incorporation of recently produced naive
T cells in the human peripheral pool. Proc. Natl.
Acad. Sci. USA 105, 6115–6120. (doi:10.1073/pnas.
0709713105)
131. Westera L et al. 2013 Closing the gap between T-
cell life span estimates from stable isotope-labeling
studies in mice and humans. Blood 122, 2205–
2212. (doi:10.1182/blood-2013-03-488411)
132. Vrisekoop N et al. 2015 Quantification of naive and
memory T-cell turnover during HIV-1 infection.
AIDS. 29, 2071–2080. (doi:10.1097/QAD.
0000000000000822)
133. De Boer RJ, Perelson AS. 2013 Quantifying T
lymphocyte turnover. J. Theor. Biol. 327, 45–87.
(doi:10.1016/j.jtbi.2012.12.025)
134. Meyer-Hermann M, Mohr E, Pelletier N, Zhang Y,
Victora GD, Toellner KM. 2012 A theory of germinal
center B cell selection, division, and exit. Cell Rep. 2,
162–174. (doi:10.1016/j.celrep.2012.05.010)
135. Dustin ML, Meyer-Hermann M. 2012 Antigen feast
or famine. Science 335, 408–409. (doi:10.1126/
science.1218165)
136. Smith AM, Adler FR, Ribeiro RM, Gutenkunst RN,
McAuley JL, McCullers JA, Perelson AS. 2013 Kinetics
of coinfection with influenza A virus and
Streptococcus pneumoniae. PLoS Pathog. 9,
e1003238. (doi:10.1371/journal.ppat.1003238)
137. Gillard JJ, Laws TR, Lythe G, Molina-Par´ıs C. 2014
Modeling early events in Francisella tularensis
rsfs.royalsocietypublishing.org
Interface
Focus
6:20150093
14
 on April 15, 2016http://rsfs.royalsocietypublishing.org/Downloaded from pathogenesis. Front. Cell Infect. Microbiol. 4, 169.
(doi:10.3389/fcimb.2014.00169)
138. O’Neill LA, Golenbock D, Bowie AG. 2013 The history
of Toll-like receptors—redefining innate immunity.
Nat. Rev. Immunol. 13, 453–460. (doi:10.1038/
nri3446)
139. Netea MG, Latz E, Mills KH, O’Neill LA. 2015 Innate
immune memory: a paradigm shift in
understanding host defense. Nat. Immunol. 16,
675–679. (doi:10.1038/ni.3178)
140. Heath WR, Carbone FR. 2013 The skin-resident and
migratory immune system in steady state and
memory: innate lymphocytes, dendritic cells and T
cells. Nat. Immunol. 14, 978–985. (doi:10.1038/ni.
2680)
141. Chylek LA, Harris LA, Faeder JR, Hlavacek WS. 2015
Modeling for ( physical) biologists: an introduction
to the rule-based approach. Phys. Biol. 12, 045007.
(doi:10.1088/1478-3975/12/4/045007)
142. Stites EC, Aziz M, Creamer MS, Von Hoff DD, Posner
RG, Hlavacek WS. 2015 Use of mechanistic models
to integrate and analyze multiple proteomic
datasets. Biophys. J. 108, 1819–1829. (doi:10.
1016/j.bpj.2015.02.030)143. Munsky B, Neuert G, van Oudenaarden A. 2012
Using gene expression noise to understand gene
regulation. Science 336, 183–187. (doi:10.1126/
science.1216379)
144. Korem Y, Szekely P, Hart Y, Sheftel H, Hausser J,
Mayo A, Rothenberg ME, Kalisky T, Alon U. 2015
Geometry of the gene expression space of individual
cells. PLoS Comput. Biol. 11, e1004224. (doi:10.
1371/journal.pcbi.1004224)
145. Intosalmi J, Ahlfors H, Rautio S, Mannerstom H,
Chen ZJ, Lahesmaa R, Stockinger B, La¨hdesma¨ki H.
2015 Analyzing Th17 cell differentiation dynamics
using a novel integrative modeling framework for
time-course RNA sequencing data. BMC Syst. Biol. 9,
81. (doi:10.1186/s12918-015-0223-6)
146. Chylek LA, Wilson BS, Hlavacek WS. 2014 Modeling
biomolecular site dynamics in immunoreceptor
signaling systems. Adv. Exp. Med. Biol. 844,
245–262. (doi:10.1007/978-1-4939-2095-2_12)
147. Lloyd CM, Halstead MD, Nielsen PF. 2004 CellML: its
future, present and past. Prog. Biophys. Mol. Biol. 85,
433–450. (doi:10.1016/j.pbiomolbio.2004.01.004)
148. The systems biology markup language. See http://
sbml.org.149. JSim. See http://physiome.org/jsim/.
150. Spitzer MH et al. 2015 An interactive reference
framework for modeling a dynamic immune system.
Science 349, 1259425. (doi:10.1126/science.1259425)
151. Perie L, Hodgkin PD, Naik SH, Schumacher TN, de
Boer RJ, Duffy KR. 2014 Determining lineage
pathways from cellular barcoding experiments. Cell
Rep. 6, 617–624. (doi:10.1016/j.celrep.2014.01.016)
152. Gerlach C et al. 2013 Heterogeneous
differentiation patterns of individual CD8þ T cells.
Science 340, 635–639. (doi:10.1126/science.
1235487)
153. Quantitative T cell Immunology. Marie Curie Initial
Training Network. See http://www1.maths.leeds.ac.
uk/applied/QUANTI/.
154. European Network Linking Informatics and
Genomics of Helper T Cells Comprising TEN
Beneficiaries. See http://www.enlight-ten.eu/.
155. Indo-European Network: Mathematics for Health
and Disease. See http://www1.maths.leeds.ac.uk/
applied/INDOMATH/.
156. International Network in Theoretical
Immunology. See http://www1.maths.leeds.ac.uk/
applied/INTI/.
